Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Rajkumar

Showing results (591-600 of 602) with videos related to

Pageof 61
Sort By:
Blood Advances|April 22, 2026
A multi-center study of progression-risk and outcomes in solitary bone plasmacytoma with and without marrow involvementKenneth Jc Lim, Maximilian Johannes Steinhardt, Matthew J Rees, et al.
JAMA Oncology|January 6, 2017
Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016Prashant Kapoor, Stephen M Ansell, Rafael Fonseca, et al.
Nature|March 25, 2011
Initial genome sequencing and analysis of multiple myelomaMichael A Chapman, Michael S Lawrence, Jonathan J Keats, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 14, 2022
Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?Angelica Macauda, Alyssa Clay-Gilmour, Thomas Hielscher, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 3, 2015
American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple MyelomaSergio Giralt, Laurent Garderet, Brian Durie, et al.
International Journal of Cancer|March 11, 2026
ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significanceJosé Manuel Sánchez-Maldonado, Angelica Macauda, Antonio José Cabrera-Serrano, et al.
International Journal of Cancer|September 9, 2022
A pleiotropic variant in DNAJB4 is associated with multiple myeloma riskMarco Dicanio, Matteo Giaccherini, Alyssa Clay-Gilmour, et al.
British Journal of Haematology|March 24, 2026
Circulating levels of insulin-like growth factor I (IGF-I) and risk of multiple myeloma: An observational and Mendelian randomisation studyYolanda Benavente, Sara Hermosa, Nikos Papadimitriou, et al.
The Lancet. Oncology|March 4, 2021
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working GroupPhilippe Moreau, Shaji K Kumar, Jesús San Miguel, et al.
Leukemia|June 22, 2022
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid NeoplasmsRita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, et al.
Pageof 61

Showing results (591-600 of 602) with videos related to

Sort By:
Pageof 61
Blood Advances|April 22, 2026
A multi-center study of progression-risk and outcomes in solitary bone plasmacytoma with and without marrow involvementKenneth Jc Lim, Maximilian Johannes Steinhardt, Matthew J Rees, et al.
JAMA Oncology|January 6, 2017
Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016Prashant Kapoor, Stephen M Ansell, Rafael Fonseca, et al.
Nature|March 25, 2011
Initial genome sequencing and analysis of multiple myelomaMichael A Chapman, Michael S Lawrence, Jonathan J Keats, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 14, 2022
Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?Angelica Macauda, Alyssa Clay-Gilmour, Thomas Hielscher, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 3, 2015
American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple MyelomaSergio Giralt, Laurent Garderet, Brian Durie, et al.
International Journal of Cancer|March 11, 2026
ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significanceJosé Manuel Sánchez-Maldonado, Angelica Macauda, Antonio José Cabrera-Serrano, et al.
International Journal of Cancer|September 9, 2022
A pleiotropic variant in DNAJB4 is associated with multiple myeloma riskMarco Dicanio, Matteo Giaccherini, Alyssa Clay-Gilmour, et al.
British Journal of Haematology|March 24, 2026
Circulating levels of insulin-like growth factor I (IGF-I) and risk of multiple myeloma: An observational and Mendelian randomisation studyYolanda Benavente, Sara Hermosa, Nikos Papadimitriou, et al.
The Lancet. Oncology|March 4, 2021
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working GroupPhilippe Moreau, Shaji K Kumar, Jesús San Miguel, et al.
Leukemia|June 22, 2022
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid NeoplasmsRita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, et al.
Pageof 61